(S (NP (NP (NN Machine) (NN learning)) (CC and) (NP (JJ deep) (NN learning))) (VP (VBP have) (VP (VP (VBN gained) (NP (NN popularity))) (CC and) (VP (VBD achieved) (NP (JJ immense) (NN success))) (PP (IN in) (NP (NNP Drug) (NN discovery))) (PP (IN in) (NP (JJ recent) (NNS decades))))) (. .))
(S (ADVP (RB Historically)) (, ,) (NP (NP (NN machine) (NN learning)) (CC and) (JJ deep) (NN learning) (NNS models)) (VP (VBD were) (VP (VBN trained) (PP (IN on) (NP (DT either) (NP (JJ structural) (NNS data)) (CC or) (NP (NN chemical) (NNS properties)))) (PP (IN by) (NP (JJ separated) (NN model))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD proposed) (NP (NP (DT an) (NN architecture)) (VP (NN training) (ADVP (RB simultaneously)) (NP (NP (DT both) (NN type)) (PP (IN of) (NP (NNS data)))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB improve) (NP (DT the) (JJ overall) (NN performance))))))))) (. .))
(S (S (VP (VBN Given) (NP (NP (DT the) (JJ molecular) (NN structure)) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (NNP SMILES) (NN notation)) (CC and) (NP (PRP$ their) (NN label))))))))) (, ,) (NP (PRP we)) (VP (VBD generated) (NP (NP (DT the) (JJ SMILES-based) (NN feature) (NN matrix)) (CC and) (NX (JJ molecular) (NNS descriptors)))) (. .))
(S (NP (DT These) (NNS data)) (VP (VBD were) (VP (VBN trained) (PP (IN on) (NP (NP (DT a) (JJ deep) (NN learning) (NN model)) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADVP (RB also)) (VP (VBN integrated) (PP (IN with) (NP (DT the) (NNP Attention) (NN mechanism))) (S (VP (TO to) (VP (VB facilitate) (NP (NN training) (CC and) (NN interpreting))))))))))))) (. .))
(S (NP (NNS Experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (PRP$ our) (NN model)) (VP (MD could) (VP (VB raise) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NN prediction)))) (S (VP (VBG comparing) (PP (TO to) (NP (DT the) (NN reference)))))))))) (. .))
(S (PP (IN With) (NP (NP (NP (DT the) (JJ maximum) (NX (NNP MCC)) (NP (CD 0.58))) (CC and) (NP (NP (NNP AUC)) (NP (CD 90) (NN %)))) (PP (IN by) (NP (NP (NN cross-validation)) (PP (IN on) (NP (NNP EGFR) (NNS inhibitors) (VBD dataset))))))) (, ,) (NP (PRP$ our) (NN architecture)) (VP (VBD was) (VP (VBG outperforming) (NP (DT the) (VBG referring) (NN model)))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (ADVP (RB successfully)) (JJ integrated) (NP (NNP Attention) (NN mechanism)) (PP (IN into) (NP (PRP$ our) (NN model))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD helped) (S (VP (TO to) (VP (VB interpret) (NP (NP (DT the) (NN contribution)) (PP (IN of) (NP (JJ chemical) (NNS structures))) (PP (IN on) (NP (NN bioactivity))))))))))) (. .))
